Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 108.61 billion as of January 6, 2026. Its market cap has increased by 20.13% in one year.

Market Cap

108.61B

Enterprise Value

119.24B

Revenue

21.64B

Ranking

n/a

PE Ratio

18.00

Stock Price

117.80

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 108.61B, an increase of 78,188.39%. That is a compound annual growth rate of 21.67%.

Market Cap History

Date	Market Cap	% Change
Jan 2, 2026	111.83B	-1.16%
Dec 31, 2025	113.14B	23.05%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	210.77B
HSBC Holdings	204.35B
Shell	157.86B
Unilever	106.78B
Rio Tinto Group	102.22B
Rolls-Royce Holdings	100.20B
British American Tobacco p.l.c.	91.02B
GSK plc	73.48B

Market Cap Rankings